364 related articles for article (PubMed ID: 31167905)
21. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.
Yoo L; Speck SH
J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007
[TBL] [Abstract][Full Text] [Related]
22. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
[TBL] [Abstract][Full Text] [Related]
23. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.
Jiang S; Willox B; Zhou H; Holthaus AM; Wang A; Shi TT; Maruo S; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):421-6. PubMed ID: 24344258
[TBL] [Abstract][Full Text] [Related]
25. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.
Chau CM; Zhang XY; McMahon SB; Lieberman PM
J Virol; 2006 Jun; 80(12):5723-32. PubMed ID: 16731911
[TBL] [Abstract][Full Text] [Related]
27. Phase Separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP Controls Gene Expression.
Peng Q; Wang L; Qin Z; Wang J; Zheng X; Wei L; Zhang X; Zhang X; Liu C; Li Z; Wu Y; Li G; Yan Q; Ma J
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941785
[TBL] [Abstract][Full Text] [Related]
28. Switching of EBV cycles between latent and lytic states.
Murata T; Tsurumi T
Rev Med Virol; 2014 May; 24(3):142-53. PubMed ID: 24339346
[TBL] [Abstract][Full Text] [Related]
29. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
30. Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
Kawane T; Komori H; Liu W; Moriishi T; Miyazaki T; Mori M; Matsuo Y; Takada Y; Izumi S; Jiang Q; Nishimura R; Kawai Y; Komori T
J Bone Miner Res; 2014 Sep; 29(9):1960-9. PubMed ID: 24692107
[TBL] [Abstract][Full Text] [Related]
31. Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.
Ke L; Zhou H; Wang C; Xiong G; Xiang Y; Ling Y; Khabir A; Tsao GS; Zeng Y; Zeng M; Busson P; Kieff E; Guo X; Zhao B
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9683-9688. PubMed ID: 28831010
[TBL] [Abstract][Full Text] [Related]
32. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
[TBL] [Abstract][Full Text] [Related]
33. A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth.
Wang C; Liu X; Liang J; Narita Y; Ding W; Li D; Zhang L; Wang H; Leong MML; Hou I; Gerdt C; Jiang C; Zhong Q; Tang Z; Forney C; Kottyan L; Weirauch MT; Gewurz BE; Zeng MS; Jiang S; Teng M; Zhao B
Nat Commun; 2023 Mar; 14(1):1598. PubMed ID: 36949074
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
[TBL] [Abstract][Full Text] [Related]
35. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
[TBL] [Abstract][Full Text] [Related]
36. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival.
Liang JH; Wang C; Yiu SPT; Zhao B; Guo R; Gewurz BE
mBio; 2021 Aug; 12(4):e0153021. PubMed ID: 34281398
[TBL] [Abstract][Full Text] [Related]
38. RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.
Gunnell A; Webb HM; Wood CD; McClellan MJ; Wichaidit B; Kempkes B; Jenner RG; Osborne C; Farrell PJ; West MJ
Nucleic Acids Res; 2016 Jun; 44(10):4636-50. PubMed ID: 26883634
[TBL] [Abstract][Full Text] [Related]
39. MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.
Wood CD; Veenstra H; Khasnis S; Gunnell A; Webb HM; Shannon-Lowe C; Andrews S; Osborne CS; West MJ
Elife; 2016 Aug; 5():. PubMed ID: 27490482
[TBL] [Abstract][Full Text] [Related]
40. Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation.
Mitra B; Beri NR; Guo R; Burton EM; Murray-Nerger LA; Gewurz BE
bioRxiv; 2023 Oct; ():. PubMed ID: 37090591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
